GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION
GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION
Approved
DIN Number
02473615
Drug Class
Human
Market Date
N/A
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473615
AIG Number0260050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AL07 FORMOTEROL AND GLYCOPYRRONIUM BROMIDE
Product Specifications
Dosage FormAerosol, Metered Dose
Route of AdministrationInhalation
AHFS Classification12:12.08.12
Health Canada Classification
ACTIVE INGREDIENTS (2)
FORMOTEROL FUMARATE DIHYDRATEActive
Strength: 5.8 MCG / ACT
Monograph: FORMOTEROL FUMARATE DIHYDRATE
GLYCOPYRRONIUM (GLYCOPYRROLATE)Active
Strength: 8.3 MCG / ACT
Monograph: GLYCOPYRRONIUM (GLYCOPYRROLATE)